Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Regen Biopharma Inc (RGBP)

Regen Biopharma Inc (RGBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0200 +325.00%
on 11/11/24
0.2699 -68.51%
on 11/08/24
-0.1400 (-62.22%)
since 10/22/24
3-Month
0.0200 +325.00%
on 11/11/24
0.2700 -68.52%
on 10/16/24
-0.0150 (-15.00%)
since 08/22/24
52-Week
0.0200 +325.00%
on 11/11/24
0.7500 -88.67%
on 12/19/23
-0.5535 (-86.69%)
since 11/22/23

Most Recent Stories

More News
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerateâ„¢

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive Officer

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) As 2022 comes to a close, I would like to highlight some our many accomplishments...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma Appoints Two New Scientific Advisory Board Members

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced that Dr. Ravinder Reddy, a Professor of Radiology at the University of...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma, Inc. Progresses Its DuraCAR Therapeutic

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)
Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer treatment...

RGBP : 0.0850 (+4.17%)
RGBPP : 0.0804 (-22.69%)

Key Turning Points

3rd Resistance Point 0.1732
2nd Resistance Point 0.1515
1st Resistance Point 0.1183
Last Price 0.0850
1st Support Level 0.0634
2nd Support Level 0.0417
3rd Support Level 0.0085

See More

52-Week High 0.7500
Fibonacci 61.8% 0.4711
Fibonacci 50% 0.3850
Fibonacci 38.2% 0.2989
Last Price 0.0850
52-Week Low 0.0200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar